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Background: Previous studies have shown that exercise capacity measured in metabolic equivalents (METs) is a powerful predictor of 
cardiovascular events in patients with cardiovascular risk factors or established coronary artery disease. We sought to examine the impact of 
baseline exercise capacity on cardiovascular outcomes in stable ischemic heart disease (SIHD) patients who were randomized to optimal medical 
therapy (OMT) versus percutaneous coronary intervention (PCI) + OMT in the COURAGE trial.
methods: A post hoc analysis was performed in 1,052 SIHD patients who underwent exercise treadmill testing (ETT) in the COURAGE trial (527 in 
PCI arm, 525 in OMT arm). Baseline exercise capacity was estimated from the workload achieved during ETT and was expressed in METs. Patients 
in both the arms were categorized based on METs achieved to either impaired exercise capacity (<7 METs) or intact exercise capacity (≥7 METs). 
Follow-up ranged from 2.5 to 7 years (median=4.6 years). The primary outcome measure was a composite of all-cause death or nonfatal myocardial 
infarction.
results: There was a trend towards a lower composite end point in patients with intact exercise capacity compared to patients with impaired 
exercise capacity in both OMT (HR: 0.64, 95% CI: 0.40-1.04, P=0.07) and PCI (HR: 0.67, 95% CI: 0.44-1.03, P=0.07) arms. There was no difference 
in the composite end point in patients assigned to PCI+OMT vs. OMT alone, irrespective of whether the patient had intact or impaired exercise 
capacity.
conclusions: SIHD patients with intact functional capacity had a trend toward improved outcomes in both treatment arms (PCI+OMT versus OMT 
alone). While the higher-risk subgroup of patients with impaired functional capacity might be expected to derive proportionately greater clinical 
benefit from revascularization, we could not demonstrate that those patients assigned to the PCI+OMT had a lower long-term rate of all-cause death 
or nonfatal MI as compared to patients receiving OMT alone.
